Lanlan Jing

865 citations

22 papers · 623 indexed · h-index 13

Impact in

Virology top 5%
- HIV Research and Treatment
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment

Papers in ⓘ

Infectious Diseases 17
- HIV/AIDS drug development and treatment 14
- SARS-CoV-2 and COVID-19 Research 3
Virology 13
- HIV Research and Treatment 13

Co-authors: Xinyong Liu (21 shared papers)Dongwei Kang (20 shared papers)Peng Zhan (16 shared papers)Gaochan Wu (12 shared papers)Xiangyi Jiang (7 shared papers)Xia Hao (1 shared paper)Erik De Clercq (12 shared papers)Christophe Pannecouque (12 shared papers)
Journals: European Journal of Medicinal Chemistry (4 papers)Journal of Medicinal Chemistry (3 papers)ACS Medicinal Chemistry Letters (2 papers)Bioorganic & Medicinal Chemistry (2 papers)International Journal of Molecular Sciences (2 papers)
Partner nations: China Belgium United States

In The Last Decade

Lanlan Jing

20 papers receiving 615 citations

Peers

Countries citing papers authored by Lanlan Jing

Since Specialization

Citations

This map shows the geographic impact of Lanlan Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Jing more than expected).

Fields of papers citing papers by Lanlan Jing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Jing. The network helps show where Lanlan Jing may publish in the future.

Co-authors

The 25 scholars most cited alongside Lanlan Jing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lanlan Jing Line = papers co-authored together Lanlan Jing links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Recent applications of click chemistry in drug discovery Expert Opinion on Drug Discovery ·Xiangyi Jiang, Xia Hao, Lanlan Jing, Gaochan Wu, Dongwei Kang, Xinyong Liu, Peng Zhan	2019	201
2	Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library European Journal of Medicinal Chemistry ·Gaochan Wu, Waleed A. Zalloum, Megan E. Meuser, Lanlan Jing, Dongwei Kang, Chin‐Ho Chen, Ye Tian, Fangfang Zhang, Simon Cocklin, Kuo‐Hsiung Lee, Xinyong Liu, Peng Zhan	2018	55
3	Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors RSC Advances ·Xiangyi Jiang, Gaochan Wu, Waleed A. Zalloum, Megan E. Meuser, Alexej Dick, Lin Sun, Chin‐Ho Chen, Dongwei Kang, Lanlan Jing, Ruifang Jia, Simon Cocklin, Kuo‐Hsiung Lee, Xinyong Liu, Peng Zhan	2019	53
4	Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors Drug Discovery Today ·Lanlan Jing, Gaochan Wu, Dongwei Kang, Zhongxia Zhou, Yuning Song, Xinyong Liu, Peng Zhan	2018	45
5	2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies Journal of Medicinal Chemistry ·Dongwei Kang, Francesc X. Ruiz, Yanying Sun, Da Feng, Lanlan Jing, Zhao Wang, Tao Zhang, Shenghua Gao, Lin Sun, Erik De Clercq, Christophe Pannecouque, Eddy Arnold, Peng Zhan, Xinyong Liu	2021	40
6	Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the “NNRTI Adjacent” Binding Site ACS Medicinal Chemistry Letters ·Zhipeng Huo, Heng Zhang, Dongwei Kang, Zhongxia Zhou, Gaochan Wu, Samuel Desta, Xiaofang Zuo, Zhao Wang, Lanlan Jing, Xiao Ding, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2018	33
7	Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery ACS Medicinal Chemistry Letters ·Dongwei Kang, Zhao Wang, Heng Zhang, Gaochan Wu, Tong Zhao, Zhongxia Zhou, Zhipeng Huo, Boshi Huang, Da Feng, Xiao Ding, Jian Zhang, Xiaofang Zuo, Lanlan Jing, Wei Luo, Samuel Desta Guma, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2018	29
8	Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors Communications Chemistry ·Dongwei Kang, Tong Zhao, Zhao Wang, Da Feng, Heng Zhang, Boshi Huang, Gaochan Wu, Fenju Wei, Zhongxia Zhou, Lanlan Jing, Xiaofang Zuo, Ye Tian, Vasanthanathan Poongavanam, Jacob Kongsted, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2019	29
9	In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP European Journal of Medicinal Chemistry ·Dongwei Kang, Da Feng, Lanlan Jing, Yanying Sun, Fenju Wei, Xiangyi Jiang, Gaochan Wu, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2020	27
10	Design, synthesis, and antiviral evaluation of novel hydrazone‐substituted thiophene[3,2‐d]pyrimidine derivatives as potent human immunodeficiency virus‐1 inhibitors Chemical Biology & Drug Design ·Zhao Wang, Dongwei Kang, Meng Chen, Gaochan Wu, Da Feng, Tong Zhao, Zhongxia Zhou, Zhipeng Huo, Lanlan Jing, Xiaofang Zuo, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2018	22
11	Design, synthesis, and evaluation of “dual-site”-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase European Journal of Medicinal Chemistry ·Da Feng, Xiaofang Zuo, Lanlan Jing, Chin‐Ho Chen, Fisayo A. Olotu, Hao Lin, Mahmoud E. S. Soliman, Erik De Clercq, Christophe Pannecouque, Kuo‐Hsiung Lee, Dongwei Kang, Xinyong Liu, Peng Zhan	2020	16
12	Discovery of potent HIV‐1 non‐nucleoside reverse transcriptase inhibitors by exploring the structure–activity relationship of solvent‐exposed regions I Chemical Biology & Drug Design ·Dongwei Kang, Zhao Wang, Meng Chen, Da Feng, Gaochan Wu, Zhongxia Zhou, Lanlan Jing, Xiaofang Zuo, Xiangyi Jiang, Dirk Daelemans, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2018	15
13	Development of Novel Dihydrofuro[3,4-d]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181C Journal of Medicinal Chemistry ·Dongwei Kang, Yanying Sun, Da Feng, Shenghua Gao, Zhao Wang, Lanlan Jing, Tao Zhang, Xiangyi Jiang, Hao Lin, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu	2022	14
14	Identification of novel 1,2,3-triazole isatin derivatives as potent SARS-CoV-2 3CLpro inhibitors via click-chemistry-based rapid screening RSC Medicinal Chemistry ·Xiangyi Jiang, Jing Li, Antonio Viayna, F. Javier Luque, Molly E. Woodson, Lanlan Jing, Shenghua Gao, Fabao Zhao, Minghui Xie, Károly Tóth, John E. Tavis, Ann E. Tollefson, Xinyong Liu, Peng Zhan	2023	10
15	Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIs Journal of Medicinal Chemistry ·Yanying Sun, Zhenzhen Zhou, Da Feng, Lanlan Jing, Fabao Zhao, Zhao Wang, Tao Zhang, Hao Lin, Hao Song, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu, Dongwei Kang	2022	9
16	Rapid discovery and crystallography study of highly potent and selective butylcholinesterase inhibitors based on oxime-containing libraries and conformational restriction strategies Bioorganic Chemistry ·Lanlan Jing, Wenxiu Wei, Bairu Meng, Fabien Chantegreil, Florian Nachon, Ana Martı́nez, Gaochan Wu, Huajun Zhao, Yuning Song, Dongwei Kang, Xavier Brazzolotto, Peng Zhan, Xinyong Liu	2023	7
17	Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors Molecules ·Shenghua Gao, Letian Song, Hongtao Xu, Antonios Fikatas, Merel Oeyen, Steven De Jonghe, Fabao Zhao, Lanlan Jing, Dirk Jochmans, Laura Vangeel, Yusen Cheng, Dongwei Kang, Johan Neyts, Piet Herdewijn, Dominique Schols, Peng Zhan, Xinyong Liu	2022	6
18	Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimization European Journal of Medicinal Chemistry ·Lanlan Jing, Gaochan Wu, Fabao Zhao, Xiangyi Jiang, Na Liu, Da Feng, Yanying Sun, Tao Zhang, Erik De Clercq, Christophe Pannecouque, Dongwei Kang, Xinyong Liu, Peng Zhan	2024	4
19	Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships exploration Bioorganic & Medicinal Chemistry ·Heng Zhang, Jing Li, Károly Tóth, Ann E. Tollefson, Lanlan Jing, Shenghua Gao, Xinyong Liu, Peng Zhan	2023	4
20	Multifunctional agents against Alzheimer’s disease based on oxidative stress: Polysubstituted pyrazine derivatives synthesized by multicomponent reactions Bioorganic & Medicinal Chemistry ·Wenxiu Wei, Lanlan Jing, Ye Tian, Anna Więckowska, Dongwei Kang, Bairu Meng, Dawid Panek, Justyna Godyń, Izabella Góral, Yuning Song, Xinyong Liu, Peng Zhan	2023	4

About Lanlan Jing

Lanlan Jing is a scholar working on Infectious Diseases, Virology, Organic Chemistry, Molecular Biology and Computational Theory and Mathematics, having authored 22 papers that have together received 623 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (13 papers), Computational Drug Discovery Methods (6 papers), Click Chemistry and Applications (6 papers), Biochemical and Molecular Research (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Virology (206 citations), Infectious Diseases (258 citations), Organic Chemistry (325 citations), Computational Theory and Mathematics (69 citations) and Pharmacology (61 citations). Lanlan Jing has collaborated with scholars based in China, Belgium and United States. Frequent co-authors include Xinyong Liu, Dongwei Kang, Peng Zhan, Gaochan Wu, Xiangyi Jiang, Xia Hao, Erik De Clercq, Christophe Pannecouque, Zhongxia Zhou and Da Feng. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact